Re-treatment of patients with isoniazid-resistant tuberculosis. Analysis and follow-up of 146 cases.
D000328:Adult; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003523:Cycloserine / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D005000:Ethionamide / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D007538:Isoniazid; D007612:Kanamycin / Q000627:therapeutic use; D011718:Pyrazinamide / Q000627:therapeutic use
D000995:Antitubercular Agents; D011718:Pyrazinamide; D007612:Kanamycin; D003523:Cycloserine; D005000:Ethionamide; D007538:Isoniazid